(Date:11/20/2009)...0, 2009Emergency medical service (EMS) providers i...rdiac arrests each year. Only 5 to 10 percent of ...tter quality cardiopulmonary resuscitation (CPR) p...ated with better patient outcome. The Resuscitati...al research network to study prehospital treatment...
(Date:11/20/2009)...ing 90-day supply, study finds , , FRIDA...h supply of prescription drugs is up to one-third ...to a new study. , U.S. researchers analyzed 26,...0 and 2005, and found that patients who bought a t...ved an average 29 percent in out-of-pocket costs. ...
(Date:11/20/2009)... OB/GYN warns against the new breast cancer recomm...es Task Force. These guidelines may be cost-effect...en is it wrong to be safe than sorry? , ...Task Force recommendations, published in the curre...et off a firestorm in the medical community. Major...
(Date:11/20/2009)...., Nov. 20 Omnicell, Inc...lutions to acute healthcare facilities, announced ... Piper Jaffray Healthcare Conference at the New Y...Speakers: Randall A. Lipps, founder, chairman, pr...p; CFO ,, Date: Tuesday, December 1, 2009 ,...
(Date:11/20/2009)...Newswire/ -- Today, iconic denim brand DKNY JEAN...ch of a capsule gift giving collection offered exc.... This collection is inspired by and designed for... and Giving® Program, a holiday fundraising ...o "give thanks for the healthy kids in your lives ...
Breaking Medicine News(10 mins):Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Three-Month Supply Lowers Drug Costs 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3...are twice as likely to develop rheumatoid arthriti... suggests research published ahead of print in the... support the fetal origin of disease theory, which...h blood pressure, for example, have been linked to...
...use to regulate emotions can determine both neurol...wards, a team of New York University and Rutgers U...ings, reported in the most recent issue of the jou...trategies can alter responses to negative events. ...
...at Wake Forest University Baptist Medical Center a...r a new cancer treatment will be as effective at e... in mice. , The treatment will involve transfusi...lood cells from cancer-resistant mice has previous...
...08 OptiNose announced today that it presented imp...ance of its novel nasal drug delivery device with ...hase II results indicate that the drug-device comb...tiNose presented the data at the Annual Scientific...
...wing demand for novel polymer and process developm...ment as an invaluable resource to medical device c...C (PRWEB) June 27, 2008 -- Zeus, Inc. introduced i... York. Showcasing its expertise, confidentiality,...
...N.J., June 27 /PRNewswire-FirstCall/,-- Schering-P...YSE: MRK ),announce the withdrawal of the New Dru... combination tablet., The companies also terminat... that would combine loratadine and,montelukast. Th...
Other Medicine News:Health News:NYU, Rutgers study shows how using mental strategies can alter the brain's reward circuitry 2Health News:Cancer 'cure' in mice to be tested in humans 2Health News:Cancer 'cure' in mice to be tested in humans 3Health News:OptiNose presents data on highly effective migraine treatment 2Health News:Contract Research Development Debuts at MD&M Touting Expertise, Innovation and Collaboration 2(Date:11/19/2009)..., Nov. 19 In a series of...nce, Heska Corporation (Nasdaq: HSKA ) ("Heska" o... new and improved website. The upgraded site is t...d programming to align the site with the company,s...(Logo: http://www.newscom.com/cgi-bin/prnh/20000...
(Date:11/19/2009)...lif., Nov. 19 Alexza Pha...y that its corporate presentation will be webcast ...are Conference on Wednesday, December 2, 2009 at 9...ebcast from The New York Palace Hotel in New York ...esident and CEO. ,, To access the live presen...
(Date:11/19/2009)...., Nov. 19 The D e al...of its Most Admired Corporate Dealmakers for the s... as its Most Admired Dealmaker in pharma/biotech f...s and divestitures since January 2006. ,, Over ...portfolio with a focus on high-growth, innovation-...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Appeals Court Rules in Favor of Prometheus Upholds the Patentability of Its Claims for Methods of Thiopurine Metabolite Testing 57519 1Appeals Court Rules in Favor of Prometheus Upholds the Patentability of Its Claims for Methods of Thiopurine Metabolite Testing 57519 2Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Associations Family Link Program In Connecticut 57514 1Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Associations Family Link Program In Connecticut 57514 2Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Associations Family Link Program In Connecticut 57514 3Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 1Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 2Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 3Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 4...confirms safety and HbA1c reductions seen in ische...ier clinical trials -, ORLANDO, Fla., Nov. 6 CV ...y that data from a prospectively identified,analys...-36 study showed,that Ranexa(R) (ranolazine extend...in A1c (HbA1c), increased the number of patients a...
...nd Clinic Researchers Highlight the Need For More ...al Trials, ORLANDO, Fla., Nov. 6 Cleveland Clini...n a significant minority in,cardiovascular randomi...,Lung and Blood Institute (NHLBI). Lead Author, E...enon,M.D., and a team of Cleveland Clinic research...
Other Medicine Technology:CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 2CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 3CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 4Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates 2...el is a viscous antimicrobial that contains 10% Po...pectrum germicidal action. As a preoperative patie... pooling of prepping solutions under the patient, ...e Iodine Topical Gel is film forming, creating a d...
Povidone Iodine Prep Solution (PVP-I Prep Flip-Top Cap)
Idophor PVP Scrub Winged Sponges
Triad Plus Povidone Iodine (PVP-I) Scrub Winged Sponges
Medicine Products: